NASDAQ:EXEL - Nasdaq - US30161Q1040 - Common Stock - Currency: USD
EXELIXIS INC (NASDAQ:EXEL) offers strong growth, solid profitability, and an attractive valuation, making it a compelling choice for investors seeking affordable growth stocks in the biotech sector.
EXELIXIS INC (NASDAQ:EXEL) is an undervalued biotech stock with strong profitability, financial health, and growth potential, making it a candidate for value investors.
Exelixis (EXEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
EXEL vs. ARGX: Which Stock Is the Better Value Option?
Mentions: ARGX
Exelixis' zanzalintinib/Opdivo combo shows superior efficacy for treating kidney cancer in an expansion cohort of the phase Ib/II STELLAR-002 study.
They’re less than mortgages’ upfront expenses, but they do add up.
The stock of First Solar, Inc. (NASDAQ:FSLR) took a hit on May 19, 2025, falling by over 7.5%. Let’s discuss why it happened. First Solar, Inc. (NASDAQ:FSLR) is a leading American solar technology company and a global provider of responsibly produced, eco-efficient solar modules. FSLR is unique among the ten largest solar manufacturers in the […]
On May 19, UBS analyst Manav Gupta upped Archer-Daniels-Midland Company (NYSE:ADM)’s stock from “Neutral” to “Buy,” raising the price objective to $60 from the prior target of $55. The analyst highlighted the potential policy benefits, together with an optimistic outlook for its nutrition segment, as critical drivers. The House’s budget reconciliation bill has made it […]
Does Exelixis (EXEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Explore Exelixis' (EXEL) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Berkshire has now amassed the most cash and cash equivalents in its history -- over $347 billion. The company's diverse and cash-rich businesses make it resilient during economic downturns. Despite Warren Buffett's imminent departure, the company should remain a source of stability.
EXELIXIS INC (NASDAQ:EXEL) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a standout in biotech. Review its full technical and fundamental strengths before considering an investment.
Take-Two Interactive reported fiscal fourth-quarter revenue that topped analysts’ expectations, but the gaming company's net loss and forecast disappointed.
Walmart beat quarterly expectations, but warned the "magnitude" of tariffs will cause prices to rise. Walmart (NYSE: WMT) beat estimates for the quarter, but the retail giant warned of price hikes on the horizon because of tariffs. Investors are heeding the caution, sending Walmart shares down 3% as of 10:30 a.m. ET.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Companies in The News Are: ARCO,DT,EXEL,ALC
We recently published a list of These 10 Firms Blowing Up by Double Digits Today. In this article, we are going to take a look at where Polestar Automotive Holding UK PLC (NASDAQ:PSNY) stands against other firms blowing up by double digits today. Ten individual stocks soared by double digits on Wednesday, outperforming a lackluster performance […]
We recently published a list of These 10 Firms Blowing Up by Double Digits Today. In this article, we are going to take a look at where Rigetti Computing, Inc. (NASDAQ:RGTI) stands against other firms blowing up by double digits today. Ten individual stocks soared by double digits on Wednesday, outperforming a lackluster performance among Wall […]
We recently published a list of These 10 Firms Blowing Up by Double Digits Today. In this article, we are going to take a look at where Exelixis, Inc. (NASDAQ:EXEL) stands against other firms blowing up by double digits today. Ten individual stocks soared by double digits on Wednesday, outperforming a lackluster performance among Wall Street’s […]
- Global ETF assets reached record levels amid strong growth. - Crypto, thematic and active strategies are reshaping the investment landscape. - Regional adoption has accelerated, with Asia expanding rapidly.
A fellow quantum computing business is part of a major deal to expand the technology in the Middle East. This was helped by a Rigetti price target raise by an analyst. The volatile, up-and-down nature of quantum computing stocks was strongly in evidence Wednesday with sector title Rigetti Computing (NASDAQ: RGTI).
We recently published an article titled Did Jim Cramer Get These 10 Predictions Right or Wrong? In this article, we are going to take a look at where Uber Technologies, Inc. (NYSE:UBER) stands against the other stocks Jim Cramer recently talked about. During the most recent episode of Mad Money, which aired on Monday, the 12th […]
Exelixis handily beat Q1 revenue and earnings estimates. Exelixis could have more catalysts on the way later this year. Shares of Exelixis (NASDAQ: EXEL) were skyrocketing 18.5% higher at 11:05 a.m. ET on Wednesday.
Exelixis' first-quarter earnings and sales beat estimates as lead drug Cabometyx maintains momentum. The company raises its sales guidance for 2025.
CRISPR Therapeutics has an approved gene-therapy treatment still in its early growth stages. One of them is CRISPR Therapeutics (NASDAQ: CRSP). Its financials haven't been looking all that impressive and as a result, growth investors have been dumping the stock.
We recently published a list of 10 AI Stocks Surging on News and Ratings. In this article, we are going to take a look at where SoundHound AI, Inc. (NASDAQ:SOUN) stands against other AI stocks surging on news and ratings. According to Daniel Ives, global head of technology research at Wedbush Securities, the US- China […]
Although the revenue and EPS for Exelixis (EXEL) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
We recently published a list of Jim Cramer Reveals The ‘North Star’ Of Investing & Discusses These 10 Stocks. In this article, we are going to take a look at where Exelon Corporation (NASDAQ:EXC) stands against other stocks that Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer […]
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing […]